Gyre Therapeutics Stock (NASDAQ: GYRE) stock price, news, charts, stock research, profile.
Open | - |
Close | - |
Volume / Avg. | 0 / 73.23K |
Day Range | - - - |
52 Wk Range | 5.88 - 30.40 |
Market Cap | $1.31B |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 68 |
Short Interest | 2.71% |
Days to Cover | 1.16 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Gyre Therapeutics (NASDAQ:GYRE) through any online brokerage.
Other companies in Gyre Therapeutics’s space includes: Centessa Pharmaceuticals (NASDAQ:CNTA), Prothena Corp (NASDAQ:PRTA), Immatics (NASDAQ:IMTX), Arcutis Biotherapeutics (NASDAQ:ARQT) and Day One Biopharmaceutical (NASDAQ:DAWN).
There is no analysis for Gyre Therapeutics.
There is no analysis for Gyre Therapeutics to provide a consensus price target.
The stock price for Gyre Therapeutics (NASDAQ: GYRE) is $15.27 last updated July 22, 2024 at 4:01 PM EDT.
There are no upcoming dividends for Gyre Therapeutics.
Gyre Therapeutics’s Q2 earnings are confirmed for Wednesday, August 21, 2024.
There is no upcoming split for Gyre Therapeutics.
Gyre Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.